Elise N. Everett, MD

Publications

1. Everett E, Greer B, Mandel L, Goff B. The effect of body mass index on clinical features, surgical morbidity, pathologic features, and outcome in women with endometrial cancer. Gynecol Oncol 2003;90:150-157.
2. Everett EN, Heuser CC, Pastore LM, Andersen WA, Rice LW, Irvin WP, Taylor PT. Predictors of suboptimal surgical cytoreduction in women treated with initial cytoreductive surgery for advanced stage epithelial ovarian cancer. Am J Obstet Gynecol. 2005 Aug;193(2):568-74; discussion 574-6.
3. Shah C, Johnson EB, Everett E, Tamimi H, Greer B, Swisher E, and Goff B. Does size matter? Tumor size and morphology as predictors of nodal status and recurrence in endometrial cancer. Gynecol Oncol 2005 Dec;99(3):564-70.
4. Laurel W. Rice, M.D., Rebecca L. Stone, M.D., Miaohou Xu, M.D., Ph.D., Mary Galgano, M.D., Mark H. Stoler, M.D., Elise N. Everett, M.D., and Amir A. Jazaeri, M.D. Biological targets for therapeutic intervention in endometrioid endometrial adenocarcinoma and malignant mixed mullerian tumors. American Journal of Obstetrics and Gynecology (2006) 194, 1119-28.
5. Lachance JA, Everett EN, Greer B, Mandel L, Swisher E, Tamimi H, and Goff B. The effect of age on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer. Gynecol Oncol 2006 Jan 11; [Epub ahead of print]
6. Elise N. Everett, MD, Amy E. French, MD, Rebecca L. Stone, MD, Lisa M. Pastore, PhD, Amir A. Jazaeri, MD, Willie A. Andersen, and Peyton T. Taylor Jr, MD. Initial chemotherapy followed by surgical cytoreduction for the treatment of stage III/IV epithelial ovarian cancer. American Journal of Obstetrics and Gynecology (2006) 195, 568-76.

Book Chapters

1. Appleton & Lange USMLE Step 3 Review Book (4th Edition), Obstetrics and Gynecology section. (Contributing author)
2. Landes, Gynecologic Oncology Handbook. (In progress)

Presentations

1. Western Association of Gynecologic Oncologists Society, June 2002
   Everett E, Greer B, Mandel L, Goff B. The effect of body mass index on clinical features, surgical morbidity, pathologic features, and outcome in women with endometrial cancer.
2. University of Washington, Department of Obstetrics and Gynecology, Grand Rounds, May 2003
   Endometrial Cancer, A Clinical Overview
3. Mid-Atlantic Gynecologic Oncology Society, October 2003
   J Lachance, E Everett, B Greer, L Mandel, E Swisher, H Tamimi, and B Goff. The effect of age on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer.
4. Gynecologic Oncology Fellows Forum, March 2004
   Elise N. Everett, MD, Amy E. French, MD, Rebecca L. Stone, MD, Lisa M. Pastore, PhD, Amir A. Jazaeri, MD, Willie A. Andersen, and Peyton T. Taylor Jr, MD. Initial chemotherapy followed by surgical cytoreduction for the treatment of stage III/IV epithelial ovarian cancer.
5. W. Norman Thornton, Jr. Symposium, Charlottesville, Virginia, April 2004
   Neoadjuvant chemotherapy for the treatment of advanced stage epithelial ovarian cancer.
6. Mid-Atlantic Gynecologic Oncology Society, October 2004
   Elise N. Everett, MD, Amy E. French, MD, Rebecca L. Stone, MD, Lisa M. Pastore, PhD, Amir A. Jazaeri, MD, Willie A. Andersen, and Peyton T. Taylor Jr, MD. Initial chemotherapy followed by surgical cytoreduction for the treatment of stage III/IV epithelial ovarian cancer.
7. South Atlantic Association of Obstetricians and Gynecologists, January 2005
   Everett EN, Heuser CC, Pastore LM, Andersen WA, Rice LW, Irvin WP, Taylor PT. Predictors of suboptimal surgical cytoreduction in women treated with initial cytoreductive surgery for advanced stage epithelial ovarian cancer.
8. W. Norman Thornton, Jr. Symposium, Charlottesville, Virginia, April 2005
   HPV Vaccines: The promise and reality.
9. South Atlantic Association of Obstetricians and Gynecologists, January 2006
   Elise N. Everett, MD, Amy E. French, MD, Rebecca L. Stone, MD, Lisa M. Pastore, PhD, Amir A. Jazaeri, MD, Willie A. Andersen, and Peyton T. Taylor Jr, MD. Initial chemotherapy followed by surgical cytoreduction for the treatment of stage III/IV epithelial ovarian cancer.
10. University of Virginia, Department of Obstetrics and Gynecology, Grand Rounds, June 2006
    Initial chemotherapy followed by surgical cytoreduction for the treatment of stage III/IV epithelial ovarian cancer.
11. University of Virginia, Department of Obstetrics and Gynecology, Grand Rounds, April 2007
    Robotic Surgery in Gynecologic Oncology: Futuristic or Fashionable?
12. Seattle Gynecologic Society, September 2007,
    Robotic Surgery in Gynecologic Oncology: Futuristic or Fashionable?